Caplin Point Laboratories Ltd - 524742 - The Board Had Approved Interim Dividend For The Year Ended 31-03-2025 Along With The Audited Results. The Details Of The Same Is Enclosed Herewith.

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

2270.2000 -3.10 (-0.14%)

NSE Sep 16, 2025 09:30 AM

Volume: 7,022

Caplin Point Laboratories Ltd.

15 May 2025, 01:42PM

2270.20

-0.14%

Result

BSE India

The Board had approved interim dividend for the year ended 31-03-2025 along with the audited results. The details of the same is attached herewith.